Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating velpatasvir in chronic hepatitis C patients; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Velpatasvir (velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis C Virus | Phase 1 | Status: COMPLETED | Results posted: 2020-12-16